Literature DB >> 23069920

Treatment of recurrent prostate cancer following radical prostatectomy: the radiation-oncologists point of view.

H C Rischke1, S Knippen, S Kirste, A L Grosu.   

Abstract

Recurrence of prostate cancer after radical prostatectomy is a common event. Salvage radiation therapy (RT) is the mainstay of treatment in cases with recurrence defined as PSA failure, offering the chance of cure. Multiple studies showed that the lower the PSA level at the beginning of salvage RT, the better the treatment outcome. There is evidence that higher radiation doses are associated with improved PSA relapse free rates. Four different recurrence patterns exist: 1) local recurrence in the prostatectomy bed only; 2) loco-regional metastases in the pelvic lymph nodes; 3) distant metastases (most commonly nodal or osseous); 4) a combination of local and distant recurrence. Modern functional imaging modalities like magnetic resonance imaging (MRI) and choline-PET/CT offer additional information to clinical and therapeutic variables and provide high accuracy depending on the level of PSA recurrence and PSA kinetics. These image modalities are valuable tools that can be used for gross tumor volume (GTV) definition in the RT-planning process in the salvage RT setting and guide interdisciplinary salvage therapy strategies in case of locoregional relapse. We discuss the impact of MRI and choline-PET/CT in the salvage setting from the radiation-oncologist point of view.

Entities:  

Mesh:

Year:  2012        PMID: 23069920

Source DB:  PubMed          Journal:  Q J Nucl Med Mol Imaging        ISSN: 1824-4785            Impact factor:   2.346


  8 in total

1.  Furosemide diminishes ¹⁸F-fluoroethylcholine uptake in prostate cancer in vivo.

Authors:  H Christian Rischke; Teresa Beck; Werner Vach; Gesche Wieser; Anca L Grosu; Wolfgang Schultze-Seemann; Philipp T Meyer; Cordula A Jilg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-06-21       Impact factor: 9.236

Review 2.  Prognostic Utility of PET in Prostate Cancer.

Authors:  Hossein Jadvar
Journal:  PET Clin       Date:  2015-01-22

3.  Adjuvant radiotherapy after salvage lymph node dissection because of nodal relapse of prostate cancer versus salvage lymph node dissection only.

Authors:  Hans Christian Rischke; Wolfgang Schultze-Seemann; Gesche Wieser; Malte Krönig; Vanessa Drendel; Petra Stegmaier; Tobias Krauss; Karl Henne; Natalia Volegova-Neher; Daniel Schlager; Simon Kirste; Anca-Ligia Grosu; Cordula Annette Jilg
Journal:  Strahlenther Onkol       Date:  2014-10-18       Impact factor: 3.621

Review 4.  Role of choline PET/CT in guiding target volume delineation for irradiation of prostate cancer.

Authors:  S M Schwarzenböck; J Kurth; Ch Gocke; T Kuhnt; G Hildebrandt; B J Krause
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-04-11       Impact factor: 9.236

5.  Toxicity and quality of life after choline-PET/CT directed salvage lymph node dissection and adjuvant radiotherapy in nodal recurrent prostate cancer.

Authors:  Cordula A Jilg; Anja Leifert; Daniel Schnell; Simon Kirste; Natalia Volegova-Neher; Daniel Schlager; Gesche Wieser; Karl Henne; Wolfgang Schultze-Seemann; Anca-L Grosu; Hans Christian Rischke
Journal:  Radiat Oncol       Date:  2014-08-12       Impact factor: 3.481

6.  Detection of a second malignancy in prostate cancer patients by using [(18)F]Choline PET/CT: a case series.

Authors:  Martina Sollini; Francesco Pasqualetti; Marzio Perri; Gabriele Coraggio; Paolo Castellucci; Massimo Roncali; Roberto Boni; Elena Lazzeri; Maria Galeandro; Fabiola Paiar; Annibale Versari; Paola Anna Erba
Journal:  Cancer Imaging       Date:  2016-08-31       Impact factor: 3.909

7.  Anatomical mapping of lymph nodes in patients receiving salvage lymphadenectomy based on a positive 11C-choline positron emission tomography/computed tomography scan.

Authors:  Steven Deconinck; Lorenzo Tosco; Luc Merckx; Olivier Gheysens; Christophe M Deroose; Marcella Baldewijns; Birgit Weynand; Koen Van Laere; Raymond Oyen; Hein Van Poppel; Steven Joniau; Karolien E Goffin
Journal:  Cent European J Urol       Date:  2019-09-05

8.  An Incidental Finding of Mucinous Colon Cancer by (18)F-Choline PET/CT Determining a Change in Clinical Management of a Patient with Recurrent Prostate Adenocarcinoma.

Authors:  Carmelo Tuscano; Elvio Grazioso Russi; Said Al Sayyad; Stefano Pergolizzi
Journal:  Case Rep Oncol Med       Date:  2014-08-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.